This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Fred Rosner, MD; Hans W. Grünwald, MD

Arch Intern Med. 1983;143(7):1322-1323.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Aggressive multimodality treatment of neoplastic disease has resulted in improved survival and even "cure" in many patients with some cancers. The most serious and life-threatening late complication of such aggressive anticancer treatment is the occurrence of acute leukemia several years after the "cure" of the original neoplasm. Such leukemia has been described in patients with Hodgkin's disease,¹ multiple myeloma,² non-Hodgkin's lymphoma,³ chronic lymphocytic leukemia,⁴ breast cancer,⁵ other neoplasms,⁶ and even nonneoplastic diseases.⁷

Although many of these patients were treated with chemotherapy and radiotherapy, many patients received no radiotherapy at all. Drugs most frequently implicated in the causation of acute leukemia and other second neoplasms are the alkylating agents, procarbazine hydrochloride and the nitrosoureas. . . . [Full Text PDF of this Article]

Author Affiliations
Department of Medicine Queens Hospital Center Affiliation of the Long Island Jewish-Hillside Medical Center 82-68 164th St Jamaica, NY 11432

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?